Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?

被引：8

作者：

Appel, Gerald B. ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, Columbia Univ Coll Phys & Surg, Dept Med,Div Nephrol, New York, NY 10032 USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 08期

关键词：

THERAPY; ANTIGEN;

D O I：

10.1681/ASN.2012060602

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1280 / 1282

页数：3

共 50 条

[1] Rituximab as first-line treatment of pemphigus
Schmidt, Enno
LANCET, 2017, 389 (10083) : 1956 - 1958
[2] Treatment with rituximab in idiopathic membranous nephropathy
Fiorentino, Marco
Tondolo, Francesco
Bruno, Francesca
Infante, Barbara
Grandaliano, Giuseppe
Gesualdo, Loreto
Manno, Carlo
CLINICAL KIDNEY JOURNAL, 2016, 9 (06) : 788 - 793
[3] Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Fervenza, F. C.
Appel, G. B.
Barbour, S. J.
Rovin, B. H.
Lafayette, R. A.
Aslam, N.
Jefferson, J. A.
Gipson, P. E.
Rizk, D. V.
Sedor, J. R.
Simon, J. F.
McCarthy, E. T.
Brenchley, P.
Sethi, S.
Avila-Casado, C.
Beanlands, H.
Lieske, J. C.
Philibert, D.
Li, T.
Thomas, L. F.
Green, D. F.
Juncos, L. A.
Beara-Lasic, L.
Blumenthal, S. S.
Sussman, A. N.
Erickson, S. B.
Hladunewich, M.
Canetta, P. A.
Hebert, L. A.
Leung, N.
Radhakrishnan, J.
Reich, H. N.
Parikh, S. V.
Gipson, D. S.
Lee, D. K.
da Costa, B. R.
Juni, P.
Cattran, D. C.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01) : 36 - 46
[4] Rituximab for the treatment of membranous nephropathy: a single-center experience
Rigler, Andreja Ales
Jerman, Alexander
Orsag, Alesa
Kojc, Nika
Kovac, Damjan
Skoberne, Andrej
Borstnar, Spela
Haler, Zeljka Veceric
Avgustin, Nusa
Kveder, Radoslav
Ferluga, Dusan
Vizjak, Alenka
Lindic, Jelka
CLINICAL NEPHROLOGY, 2017, 88 : S27 - S31
[5] Rituximab in Membranous Nephropathy
Gauckler, Philipp
Shin, Jae Il
Alberici, Federico
Audard, Vincent
Bruchfeld, Annette
Busch, Martin
Cheung, Chee Kay
Crnogorac, Matija
Delbarba, Elisa
Eller, Kathrin
Faguer, Stanislas
Galesic, Kresimir
Griffin, Sian
van den Hoogen, Martijn W. F.
Hruskova, Zdenka
Jeyabalan, Anushya
Karras, Alexandre
King, Catherine
Kohli, Harbir Singh
Mayer, Gert
Maas, Rutger
Muto, Masahiro
Moiseev, Sergey
Odler, Balazs
Pepper, Ruth J.
Quintana, Luis F.
Radhakrishnan, Jai
Ramachandran, Raja
Salama, Alan D.
Schonermarck, Ulf
Segelmark, Marten
Smith, Lee
Tesar, Vladimir
Wetzels, Jack
Willcocks, Lisa
Windpessl, Martin
Zand, Ladan
Zonozi, Reza
Kronbichler, Andreas
KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 881 - 893
[6] Rituximab in Idiopathic Membranous Nephropathy
Ruggenenti, Piero
Cravedi, Paolo
Chianca, Antonietta
Perna, Annalisa
Ruggiero, Barbara
Gaspari, Flavio
Rambaldi, Alessandro
Marasa, Maddalena
Remuzzi, Giuseppe
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (08): : 1416 - 1425
[7] Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
Chen, Haifei
Fu, Ailin
Wang, Jing
Wu, Tianqin
Li, Zhengyang
Tang, Jieqing
Shen, Hongshi
Zhu, Jingjing
Li, Jie
Zhu, Qian
Qing, Longmei
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2017, 45 (03) : 1253 - 1260
[8] Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report
Zhang, Fan
Yang, Yiya
Chen, Yinyin
Chen, Ying
Yin, Wei
Liang, Yumei
Luo, Xun
MEDICINE, 2022, 101 (37) : E30663
[9] Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
Xu, Mingyue
Wang, Yifeng
Wu, Meihe
Chen, Ruiying
Zhao, Wenqian
Li, Mingxin
Hao, Chuan-Ming
Xie, Qionghong
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, : 978 - 986
[10] Rituximab bioavailability in primary membranous nephropathy
Boyer-Suavet, Sonia
Andreani, Marine
Cremoni, Marion
Brglez, Vesna
Benzaken, Sylvia
Bernard, Ghislaine
Nachman, Patrick
Esnault, Vincent
Seitz-Polski, Barbara
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (08) : 1423 - 1425

← 1 2 3 4 5 →